1 Jones WJ, "Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination" 32 : 2232-2236, 2001
2 Carandang R, "Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years" 296 : 2939-2946, 2007
3 Howard VJ, "The reasons for geographic and racial differences in stroke study: objectives and design" 25 : 135-143, 2005
4 Amarenco P, "The paradox of cholesterol and stroke" 370 : 1803-1804, 2007
5 Flaherty ML, "The increasing incidence of anticoagulant-associated intracerebral hemorrhage" 68 : 116-121, 2007
6 von Elm E, "The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies" 370 : 1453-1457, 2007
7 Moher D, "The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials" 1 : 2-, 2001
8 Bonita R, "Stroke prevention in poor countries: time for action" 38 : 2871-2872, 2007
9 Minelli C, "Stroke incidence, prognosis, 30-day, and 1-year case fatality rates in Matão, Brazil: a population-based prospective study" 38 : 2906-2911, 2007
10 Liu M, "Stroke in China: epidemiology, prevention, and management strategies" 6 : 456-464, 2007
1 Jones WJ, "Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination" 32 : 2232-2236, 2001
2 Carandang R, "Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years" 296 : 2939-2946, 2007
3 Howard VJ, "The reasons for geographic and racial differences in stroke study: objectives and design" 25 : 135-143, 2005
4 Amarenco P, "The paradox of cholesterol and stroke" 370 : 1803-1804, 2007
5 Flaherty ML, "The increasing incidence of anticoagulant-associated intracerebral hemorrhage" 68 : 116-121, 2007
6 von Elm E, "The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies" 370 : 1453-1457, 2007
7 Moher D, "The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials" 1 : 2-, 2001
8 Bonita R, "Stroke prevention in poor countries: time for action" 38 : 2871-2872, 2007
9 Minelli C, "Stroke incidence, prognosis, 30-day, and 1-year case fatality rates in Matão, Brazil: a population-based prospective study" 38 : 2906-2911, 2007
10 Liu M, "Stroke in China: epidemiology, prevention, and management strategies" 6 : 456-464, 2007
11 Vermeer SE, "Silent brain infarcts: a systematic review" 6 : 611-619, 2007
12 Pandian JD, "Poverty and stroke in india: a time to act" 38 : 3063-3069, 2007
13 "Namwon Study" 2007
14 Vernooij MW, "Incidental findings on brain MRI in the general population" 357 : 1821-1828, 2007
15 Wang X, "Efficacy of folic acid supplementation in stroke prevention: a metaanalysis" 369 : 1876-1882, 2007
16 Zhang XH, "Disparity and its time trends in stroke mortality between urban and rural populations in China 1987 to 2001: changing patterns and their implications for public health policy" 38 : 3139-3144, 2007
17 Wadley VG, "Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study" 38 : 1143-1147, 2007
18 Lovelock CE, "Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study" 6 : 487-493, 2007
19 Prospective Studies Collaboration, "Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths" 370 : 1829-1839, 2007
20 Cook NR, "A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the women’s Antioxidant Cardiovascular study" 167 : 1610-1618, 2007